Medroxyprogesterone Acetate Injection, Suspension
Product Images NDC 62756-091

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Medroxyprogesterone Acetate (NDC 62756-091). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl-medroxy-fig1 (Spl Medroxy Fig1)

The figure shows risk estimates on a logarithmic scale for breast cancer in users of DMPA (Depo-Provera) over a variety of studies conducted from 1987 to 2012. The odds ratios and 95% confidence intervals from Lee et al. (1987), Paul et al. (1989), the World Health Organization (WHO) in 1991, Shapiro et al. (2000), and Li et al. (2012) are displayed. The odds ratios presented are higher than 1, indicating an increased risk of breast cancer with DMPA use for all subjects and those using DMPA for 12 months or longer.*

FDA Label Image

Spl-medroxy-pfs-carton (Spl Medroxy Pfs Carton)

This is a description of a medication called medroxyPROGESTERone Acetate Injectable Suspension, USP. It is a single-dose syringe for intramuscular use only and must be shaken before use. The dosage and use instructions can be found in the accompanying prescribing information. The medication contains medroxyprogestrone acetate, polyethylene glycol 3350, sodium chloride, and preservatives. It must be stored at a controlled room temperature and pH may be adjusted if necessary.*

FDA Label Image

Spl-medroxy-pfs-label (Spl Medroxy Pfs Label)

This is a description of a prescription-only medication called medroxyPROGESTERone Acetate Injectable Suspension, USP. It comes in a 1 mL single-dose syringe with a concentration of 150 mg/mL and is intended for intramuscular use only. It should be shaken vigorously before use. The medication is manufactured by Sun Pharmaceutical Ind. Ltd. in India and distributed by Sun Pharmaceutical Ind., Inc. in New Jersey.*

FDA Label Image

Spl-medroxy-pil (Spl Medroxy Pil)

This is an evaluation of different birth control methods. It mentions the rate of pregnancy per 100 women, which is fewer than 1. It suggests that having 10-20 pregnancies per 100 women is common, whereas having 85 or more pregnancies per 100 women is rare. Various methods such as implants, injections, intrauterine devices, sterilization, birth control pills, skin patches, and vaginal ring with hormones are listed. Condoms and diaphragms are also mentioned as contraception methods. Abstinence from sex during the most fertile days of the menstrual cycle is suggested as another option. The text provides information to help individuals make informed choices about birth control.*

FDA Label Image

Spl-medroxy-structure (Spl Medroxy Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.